Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-04-25
2006-04-25
Monshipouri, Maryam (Department: 1653)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C530S350000
Reexamination Certificate
active
07033771
ABSTRACT:
Methods of identifying insulin response modulators are provided. Therapeutic methods utilizing compounds identified according to the methods of the invention are also provided. In particular, methods of treating diabetes and insulin resistance are provided.
REFERENCES:
patent: 5968764 (1999-10-01), Knowles et al.
Barroso et al., “Transcytosis-associated protein (TAP)/p 115 is a general fusion factor required for binding of vesicles to acceptor membranes”, Proc. Natl. Acad. Sci. USA. Jan. 17, 1995; 92(2):527-531.
Bastiaens et al., “Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell”, Trends Cell Biol. Feb. 1999; 9(2):48-52.
Curran et al., “Nonprimate lentiviral vectors” Curr Top Miscrobiol Immunol. 2002; 261:75-105.
Elazar et al., “ADP-ribosylation factor and coatomer couple fusion to vesicle budding” J Cell Biol. Feb. 1994; 124(4):415-424.
Fischer A., “Gene therapy: Some results, many problems to solve” Cell Mol Biol. Dec. 2001; 47(8):1269-1275.
Hemminki A., “From molecular changes to customised therapy” Eur J Cancer. Feb. 2002; 38(3): 333-338.
Henriksen E.J., “Invtied review: Effects of acute exercise and exercise training on insulin resistance” J Appl Physiol. Aug. 2002; 93(2):788-796.
Herman et al., “A distinct class of intracellular storage vesicles, identified by expression of the glucose transporter GLUT4” Proc Natl Acad Sci USA. Dec. 20, 1994; 91(26):12750-12754.
Hertzel et al. “Adenovirus-mediated gene transfer in primary murine adipocytes”, J Lipid Res. Jul. 2000; 41(7):1082-1086.
Lemons et al., “Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery” Blood. Aug. 15, 1997; 90(4): 1490-1500.
Levine et al., “Binding of the vesicle docking protein p115 to Golgi membranes is inhibited under mitotic conditions” J Biol Chem. Jul. 19, 1996; 271(29):17304-17311.
Meyer et al., “Gene therapy:progress and challenges” Cell Mol Biol. Dec. 2001; 47(8):1277-1294.
Nakajima et al., “A cytoskeleton-related gene, USO1, is required for intracellular protein transport inSaccharomyces cerevisiae” J Cell Biol. Apr. 1991; 113(2):245-260.
Nelson et al., “The membrane transport factor Tap/p115 cycles between the Golgi and earlier secretory compartments and contains distinct domains required for its localization and function” J Cell Biol. Oct. 19, 1998 143(2):319-331.
Richards-Smith et al., “Analyses of proteins involved in vesicular trafficking in platelets of mouse models of Hermansky Pudiak syndrome” Mol Genet Metab. Sep. 1999; 68(1):14-23.
Sapperstein et al., “p115 is a general vesicular transport factor related to the yeast endoplasmic reticulum to Golgi transport factor Uso1p” Proc Natl Acad Sci USA. Jan. 17, 1995; 92(2):522-526.
Sohda et al., “Phosphorylation of the vesicle docking protein p115 regulates its association with the Golgi membrane” J Biol Chem. Feb. 27, 1998; 273(9):5385-5388.
Szolloal et al., “Application of fluorescence resonance energy transfer in the clinical laboratory: routine and research” Cytometry. Aug. 15, 1998; 34(4):159-179.
Sztul et al., “Control of protein traffic between distinct plasma membrane domains. Requirement for a novel 108,000 protein in the fusion of transcytotic vesicles with the apical plasma membrane” J Biol Chem. Jan. 25, 1993; 268(3):1876-1885.
Sztul et al., “Transcytotic vesicle fustion with plasma membrane” Methods in Enzymology. 1992; 219:49-51.
Tavare et al., “Lighting up insulin action” Diabet Med. Arp 2001; 18(4):253-260.
Waters et al., “A novel 115-kD peripheral membrane protein is required for intercisternal transport in the Golgi stack” J Cell Biol. Sep. 1992; 118(5):1015-1026.
Wattenberg et al., “The molecular control of transport vesicle fusion” New Biol. Jun. 1990; 2(6):505-511.
Wilson et al., “A fusion protein required for vesicle-mediated transport in both mammalian cells and yeast” Nature. Jun. 1, 1989; 339(6223):355-359.
Wilson et al., “ Intracellular membrane fusion” Trends Biochem Sci. Sep. 1991; 16(9):334-337.
Han et al., Genbank Accession No. AAC72967 for identification of Mouse TAP (Nov. 12, 1998).
Misumi Y., Genbank Accession No. BAA25300 for Phosphorylation of the Vesicle (Mar. 17, 1999).
Genome Sequencing Consortium. Genbank Accession No. NP—062252 for Direct Submission (Dec. 12, 2001).
Alvarez et al. Genbank Accession No. NP—003706 for the p115-interactive proteins (Jan. 8, 2001).
Sapperstein et al. Genbank Accession No. P41541 for p115 us a general vesicular transport factor (Apr. 30, 2001).
Sapperstein et al. Genbank Accession No. P41542 for p115 is a general vesibular transport factor (Apr. 30, 2001).
Waters et al. Proteins Involved in Vesicular Transport and Membrane Function. Current Opinion in Cell Biology. Aug. 1991. vol. 3, no. 4, pp.615-620.
Lahive & Cockfield LLP
Mayer Suzanne M.
Milasincic Debra J.
Monshipouri Maryam
Takeda Pharmaceutical Company Limited
LandOfFree
Use of insulin response modulators in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of insulin response modulators in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of insulin response modulators in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3562576